# FDA Inspection 966039 - SOFIE Co. dba SOFIE - March 18, 2016

Source: https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/4e98c4e4-0639-445b-aebe-f5913951fb91
Source feed: FDA_Inspections

> FDA Inspection 966039 for SOFIE Co. dba SOFIE on March 18, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 966039
- Company Name: SOFIE Co. dba SOFIE
- Inspection Date: 2016-03-18
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1280292 - 2025-08-28](https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/f281f4bb-bf39-41b2-9fdc-c6b2cd5ab649)
- [FDA Inspection 882139 - 2014-06-06](https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/0387d49b-728d-4937-ad47-164a9a8845a6)
- [FDA Inspection 794296 - 2012-08-16](https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/6bd0fc2f-488a-4d55-a1b2-044ff99899e8)

Company: https://www.keypedia.com/companies/sofie-co-dba-sofie/c683c431-3e42-49e6-a2fa-20743b596202

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c